Comparison of chlorzoxazone one-sample methods to estimate CYP2E1 activity in humans
- 1 December 2003
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 59 (10) , 775-778
Abstract
Comparison of a one-sample with a multi-sample method (the metabolic fractional clearance) to estimate CYP2E1 activity in humans. Healthy, male Caucasians (n=19) were included. The multi-sample fractional clearance (Clfe) of chlorzoxazone was compared with one-time-point clearance estimation (Clest) at 3, 4, 5 and 6 h. Furthermore, the metabolite/drug ratios (MRs) estimated from one-time-point samples at 1, 2, 3, 4, 5 and 6 h were compared with Clfe. The concordance between Clest and Clfe was highest at 6 h. The minimal mean prediction error (MPE) of Clest as a percentage of actual mean Clfe was −4.2% at 6 h. Furthermore, regarding Clfe, there was a negligible difference (P=0.56) of bias between Clest at 3 h (MPE=−8.9%) and 6 h (MPE=−4.2%). The best concordance between MR and Clfe was found at 3 h (r=0.74; Pest at 3 h or 6 h, and MR at 3 h, can serve as reliable markers of CYP2E1 activity. The one-sample clearance method is an accurate, renal function-independent measure of the intrinsic activity; it is simple to use and easily applicable to humans.Keywords
This publication has 11 references indexed in Scilit:
- Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humansPharmacogenetics, 1999
- Use of Chlorzoxazone as an In Vivo Probe of Cytochrome P450 2E1: Choice of Dose and Phenotypic Trait MeasureThe Journal of Clinical Pharmacology, 1998
- Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms*Clinical Pharmacology & Therapeutics, 1995
- Decrease in Cytochrome P4502E1 as Assessed by the Rate of Chlorzoxazone Hydroxylation in Alcoholics during the Withdrawal PhaseAlcohol, Clinical and Experimental Research, 1995
- Selectivity of cytochrome P4502E1 in chlorzoxazone 6-hydroxylation.Drug Metabolism and Disposition, 1995
- Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: A putative probe of CYP2E1 activityClinical Pharmacology & Therapeutics, 1994
- Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokineticsBiochemical Pharmacology, 1994
- Single-dose disulfiram inhibition of chlorzoxazone metabolism: A clinical probe for P450 2E1Clinical Pharmacology & Therapeutics, 1993
- High-performance liquid chromatography with electrochemical detection of chlorzoxazone and its hydroxy metabolite in serum using solid-phase extractionJournal of Chromatography B: Biomedical Sciences and Applications, 1986
- Optimal sampling times for minimum variance of clearance determination.British Journal of Clinical Pharmacology, 1983